Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1.
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1.
复制标题
DOI:
10.3390/molecules26051227
复制
发表时间:
2021-02-25
期刊:
影响因子:
--
通讯作者:
Flaherty DP
中科院分区:
文献类型:
--
作者:
Krabill AD;Chen H;Hussain S;Hewitt CS;Imhoff RD;Muli CS;Das C;Galardy PJ;Wendt MK;Flaherty DP
The deubiquitinating enzyme (DUB) UCHL1 is implicated in various disease states including neurodegenerative disease and cancer. However, there is a lack of quality probe molecules to gain a better understanding on UCHL1 biology. To this end a study was carried out to fully characterize and optimize the irreversible covalent UCHL1 inhibitor VAEFMK. Structure-activity relationship studies identified modifications to improve activity versus the target and a full cellular characterization was carried out for the first time with this scaffold. The studies produced a new inhibitor, 34, with an IC50 value of 7.7 µM against UCHL1 and no observable activity versus the closest related DUB UCHL3. The molecule was also capable of selectively inhibiting UCHL1 in cells and did not demonstrate any discernible off-target toxicity. Finally, the molecule was used for initial probe studies to assess the role of UCHL1 role in proliferation of myeloma cells and migration behavior in small cell lung cancer cells making 34 a new tool to be used in the biological evaluation of UCHL1.
登录
查看更多内容
影响因子:
4.8
作者:
Garcia-Calvo, M;Peterson, EP;Thornberry, NA
通讯作者:
Thornberry, NA
影响因子:
4.8
作者:
Atkin G;Paulson H
通讯作者:
Paulson H
DOI:
10.1074/jbc.m114.557124
发表时间:
2014-12-26
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Bishop P;Rubin P;Thomson AR;Rocca D;Henley JM
通讯作者:
Henley JM
DOI:
10.1042/bcj20160082
发表时间:
2016-08-15
期刊:
The Biochemical journal
影响因子:
--
作者:
Bishop P;Rocca D;Henley JM
通讯作者:
Henley JM
影响因子:
2.6
作者:
Jara, Javier H.;Frank, Dominic D.;Oezdinler, P. Hande
通讯作者:
Oezdinler, P. Hande